Dow Jones

44,728.37

-0.41%

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
USOTC
Panacea Life Sciences Holdings Inc (PK) (PLSH)
Panacea Life Sciences Holdings Inc (PK) (PLSH) Noticias

PLSH

Panacea Life Sciences (PK) (PLSH)

Panacea Life Sciences Holdings Inc (PK)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:PLSH

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
11/06/2024	16:12	Edgar (US Regulatory)	Form 1-A - Offering Statement [Regulation A]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
16/05/2024	07:37	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
06/05/2024	08:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
08/12/2023	14:04	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
20/09/2023	11:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
15/08/2023	10:19	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
18/07/2023	11:41	InvestorsHub NewsWire	Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
23/06/2023	16:11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
12/06/2023	15:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
02/06/2023	15:07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
30/03/2023	15:08	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
30/01/2023	05:11	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
15/08/2022	06:11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
27/06/2022	15:06	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
05/04/2022	11:00	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
20/12/2021	08:17	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
17/12/2021	15:26	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)
09/12/2021	10:21	InvestorsHub NewsWire	Panacea Life Sciences, Inc. establishes a presence in Brazil as early as January 2022	USOTC:PLSH	Panacea Life Sciences Holdings Inc (PK)